Product NDC: | 59746-233 |
Proprietary Name: | Oxcarbazepine |
Non Proprietary Name: | oxcarbazepine |
Active Ingredient(s): | 300 mg/1 & nbsp; oxcarbazepine |
Administration Route(s): | ORAL |
Dosage Form(s): | TABLET, FILM COATED |
Coding System: | National Drug Codes(NDC) |
Product NDC: | 59746-233 |
Labeler Name: | JUBILANT CADISTA PHARMACEUTICALS, INC. |
Product Type: | HUMAN PRESCRIPTION DRUG |
FDA Application Number: | ANDA090239 |
Marketing Category: | ANDA |
Start Marketing Date: | 20100214 |
Package NDC: | 59746-233-01 |
Package Description: | 100 TABLET, FILM COATED in 1 BOTTLE (59746-233-01) |
NDC Code | 59746-233-01 |
Proprietary Name | Oxcarbazepine |
Package Description | 100 TABLET, FILM COATED in 1 BOTTLE (59746-233-01) |
Product NDC | 59746-233 |
Product Type Name | HUMAN PRESCRIPTION DRUG |
Non Proprietary Name | oxcarbazepine |
Dosage Form Name | TABLET, FILM COATED |
Route Name | ORAL |
Start Marketing Date | 20100214 |
Marketing Category Name | ANDA |
Labeler Name | JUBILANT CADISTA PHARMACEUTICALS, INC. |
Substance Name | OXCARBAZEPINE |
Strength Number | 300 |
Strength Unit | mg/1 |
Pharmaceutical Classes | Anti-epileptic Agent [EPC],Decreased Central Nervous System Disorganized Electrical Activity [PE] |